Nrf2-Mediated Transcriptional Induction of Antioxidant Response in Mouse Embryos Exposed to Ethanol in vivo : Implications for the Prevention of Fetal Alcohol Spectrum Disorders by Dong, Jian et al.
ANTIOXIDANTS & REDOX SIGNALING
Volume 10, Number 12, 2008
© Mary Ann Liebert, Inc.
DOI: 10.1089/ars.2007.2019
Original Research Communication
Nrf2-Mediated Transcriptional Induction of Antioxidant
Response in Mouse Embryos Exposed to Ethanol in vivo:
Implications for the Prevention of Fetal Alcohol 
Spectrum Disorders
Jian Dong, Kathleen K. Sulik, and Shao-yu Chen
Abstract
Nuclear factor erythroid 2–related factor 2 (Nrf2) is a transcription factor that is important in protection against
oxidative stress. This study was designed to determine the role of Nrf2 signaling in transcriptional activation
of detoxifying and antioxidant genes in an in vivo mouse fetal alcohol syndrome model. Maternal ethanol treat-
ment was found to increase both Nrf2 protein levels and Nrf2-ARE binding in mouse embryos. It also resulted
in a moderate increase in the mRNA expression of Nrf2 downstream target detoxifying and antioxidant genes
as well as an increase in the expression of antioxidant proteins. Pretreatment with the Nrf2 inducer, 3H-1,2
dithiole-3-thione (D3T), significantly increased Nrf2 protein levels and Nrf2-ARE binding, and strongly induced
the mRNA expression of Nrf2 downstream target genes. It also increased the expression of antioxidant pro-
teins and the activities of the antioxidant enzymes. Additionally, D3T pretreatment resulted in a significant de-
crease in ethanol-induced reactive oxygen species generation and apoptosis in mouse embryos. These results
demonstrate that Nrf2 signaling is involved in the induction of antioxidant response in ethanol-exposed em-
bryos. In addition, the potency of D3T in inducing antioxidants as well as in diminishing ethanol-induced apop-
tosis suggests that further exploration of the antiteratogenic effect of this compound will be fruitful. Antioxid.
Redox Signal. 11, 2023–2033.
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Introduction
FETAL ALCOHOL SPECTRUM DISORDERS (FASD) are among themost devastating consequences of the widespread use
and abuse of alcohol (ethanol). FASD is an umbrella term
that includes full-blown fetal alcohol syndrome (FAS) as the
severe end of the spectrum of alcohol-induced birth defects.
Prenatal ethanol exposure is considered to be the leading
known cause of mental retardation in the Western world (1).
According to a 1996 Institute of Medicine (IOM) report, the
prevalence of FAS in the United States has been estimated
at 0.5 to 3.0 cases per 1,000 births, with the full spectrum of
ethanol-induced prenatal insult projected to occur several
times as frequently (39).
Apoptotic death of selected cell populations is a com-
monly observed pathogenic feature of ethanol-induced ter-
atogenesis in both in vivo and in vitro model systems (3, 7,
11, 14, 37, 40). Among the proposed mechanisms underlying
ethanol-induced apoptosis and malformation is oxidative
stress. This is evidenced in studies from our laboratory and
others that have shown that (a) antioxidants significantly im-
prove the viability of an ethanol-sensitive cell population,
neural crest cells, in vitro (9, 10); (b) ethanol induces super-
oxide anion generation and lipid peroxidation in cultured
mouse embryos (24); (c) superoxide dismutase (SOD) can di-
minish ethanol-induced cell death and significantly reduce
the incidence of neural tube defects (24); and (d) EUK-134, a
synthetic SOD and catalase mimetic, can reduce apoptosis
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and the resulting limb defects in mouse embryos exposed to
ethanol in vivo (8).
In addition to using exogenous antioxidants to reduce ox-
idative stress in ethanol-exposed embryos, a proposed strat-
egy for protecting against oxidative damage entails chemi-
cally mediated upregulation of endogenous antioxidants.
The current study describes modulation of Nrf2, which is a
transcription factor that regulates the induction of detoxify-
ing and antioxidant genes through antioxidant response el-
ement (ARE) and, thus, plays a central role in the cellular
defense against oxidative stress. Protection mediated by Nrf2
signaling is evidenced by its role in reduction of oxidative
damage induced by acute pulmonary injury and hyperoxia
(6, 12). Additionally, Nrf2 deficiency enhances the sensitiv-
ity of neurons and astrocytes to oxidative stress by reducing
the expression of cytoprotective genes (27, 28). Nrf2-deficient
mice form higher levels of DNA adducts after exposure to
carcinogens (36). A number of studies have also shown that
Nrf2 plays an important role in cell survival (27, 28, 30).
Because Nrf2 plays a key role in the transcriptional in-
duction of various antioxidants (21) and an expansive set of
antioxidant/detoxification genes that act in synergy to re-
move ROS is essential for efficient detoxification of ROS,
identification of molecules that can induce Nrf2 activation
has recently received considerable attention. A wide variety
of natural and synthetic small molecules are potent induc-
ers of Nrf2 activity (32). Among these molecules is 3H-1,2
dithiole-3-thione (D3T). D3T is a potent cancer chemopre-
ventive agent that protects against mutation and initiation
of neoplasia (34). In addition, activation of the Nrf2 pathway
by oral administration of D3T has recently been reported to
confer partial protection against MPTP-induced neurotoxic-
ity (4). The protective effects of D3T in animals have been
associated with induction of the detoxifying and antioxidant
enzymes SOD, catalase and -glutamylcysteine synthetase
(-GCS) (5, 31, 34). Although the exact mechanisms by which
D3T activates Nrf2 signaling remain to be defined, it was
suggested that the direct interaction between D3T and the
sulfhydryl groups of Keap1 can cause dissociation of Keap1
from Nrf2, leading to Nrf2 activation (26). In addition, mi-
togen-activated protein kinases (MAPKs) have recently been
shown to be involved in the activation of Nrf2 by D3T (29).
Although it is clear that Nrf2 is a key transcription factor
in regulating a variety of cytoprotective genes in various
types of cells and tissues, the potential for this signaling path-
way to play a significant protective role relative to teratoge-
nesis by ethanol has not been previously investigated. This
study was designed to fill this void by examination of Nrf2-
mediated transcriptional activation of detoxifying and anti-
oxidant genes in ethanol-exposed mouse embryos, along
with examination of the protective effect of the Nrf2 inducer,
D3T. To this end, we have examined the levels of Nrf2 pro-
tein and Nrf2-ARE binding activity and have analyzed
mRNA and protein expression of Nrf2 downstream target
genes as well as the activities of antioxidant enzymes in
mouse embryos after exposure to ethanol and D3T in vivo.
Additionally, we have determined the potential of D3T to
prevent ethanol-induced oxidative stress and apoptosis in
mouse embryos. The results of this study demonstrate that
Nrf2 signaling is involved in the induction of antioxidants
and detoxifying enzymes in ethanol-exposed mouse em-
bryos and that D3T pretreatment can induce antioxidant pro-
teins and phase 2 enzymes and prevent ethanol-induced
apoptosis.
Materials and Methods
Animal care and dosing
C57BL/6J mice (The Jackson Laboratory, Bar Harbor,
ME) were mated for 2 h early in the light cycle. The time
of vaginal-plug detection was considered 0 days, 0 h of
gestation (GD 0:0). Mice were maintained on an ad libitum
diet of breeder chow and water. Animals in the experi-
mental groups were administered two intraperitoneal (i.p.)
doses of 25.0% (vol/vol) ethanol in lactated Ringer’s solu-
tion at a dosage of 2.9 g/kg maternal body weight. Con-
trol dams were administered lactated Ringer’s solution
alone. The injections were given 4 h apart, with the first
administered at GD 8:0. For D3T pretreatment, pregnant
mice were given i.p. injections of either D3T (LKT Labo-
ratories, Inc., St. Paul, MN) at a dosage of 5 mg/kg or its
solvent (vegetable oil) on GD 7:6 (i.e., 18 h before they were
treated with ethanol or Ringer’s solution). For mRNA and
protein analysis, pregnant females were killed by cervical
dislocation on GD 8:6 (6 h after the first ethanol treatment).
For apoptosis assays, pregnant mice were killed on GD 8:12
(12 h after the first ethanol treatment). Abdominal cavities
were surgically opened, and the uteri were exposed and
removed. Embryos were dissected free of their deciduas in
lactated Ringer’s solution and then staged by counting the
number of somite pairs. Embryos of comparable develop-
mental stage from several litters were pooled for mRNA
and protein preparation. Selection of the time points at
which analyses were conducted was based on our previ-
ous investigations, which demonstrated that significant
changes in mRNA expression can be observed by mi-
croarray assay in ethanol-exposed mouse embryos as early
as 3 h after the first ethanol treatment (18) and that exces-
sive apoptosis can be observed in ethanol-exposed mouse
embryos 12–16 h after initial treatment with ethanol (8, 14,
25). All protocols used in this study were approved by the
University of North Carolina at Chapel Hill Institutional
Animal Care and Use Committee.
RNA isolation and reverse-transcription reaction
Total RNA was isolated from whole embryos by using 
Trizol reagent (Invitrogen, CA) and cleaned with Qiagen
RNeasy Mini Kit (Qiagen, Hilden, Germany) according to
the manufacturer’s instructions. RNA quantitation was per-
formed by measuring the absorbance of the RNA sample so-
lutions at 260 nm. The RNA integrity was determined by
agarose gel electrophoresis. The RNA samples were treated
with DNase-I (Qiagen RNase-free DNase kit). The reverse
transcription reaction was carried out in a 100-l reaction by
incubation of 1 g of RNA with Oligo d(T)16 primers at 48°C
for 60 min, by using a commercially available GeneAmp
RNA PCR kit (Applied Biosystems, Foster, CA).
Quantitative real-time PCR
Quantitative real-time PCR with SYBR green I detection
(Applied Biosystems, Warrington, U.K.) was performed in a
MyiQ Single-Color Real-Time PCR Detection System (Bio-










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































were designed by using Primer Express Software (Applied
Biosystems) and synthesized by Integrated DNA Technolo-
gies, Inc (Coralville, IA). Reactions were performed in a to-
tal volume of 25 l, including 12.5 l 2  Power SYBR Green
PCR Master Mix, 1 l of 0.4 M primer, and 2.5 l of the
previously reverse-transcribed cDNA template on 96-well
iCycler iQ PCR plates (Bio-Rad). All reactions were carried
out at least in duplicate for each sample. The thermocycling
profile included 45 cycles consisting of denaturation at 95°C
for 15 sec, and annealing and elongation at 60°C for 60 sec.
Melting curve and agarose electrophoresis analysis were per-
formed to exclude amplification of nonspecific products.
GAPDH was used as a reference for normalization, and rel-
ative quantification was performed by using iCycler iQ Op-
tical System Software Version 1 (Bio-Rad).
Protein preparation and Western blotting
Embryos were washed once in phosphate-buffered saline
(PBS) and lysed by incubation for 30 min in RIPA lysis buffer
(PBS, 0.5 % sodium deoxycholate, 1% NP-40, 0.1% SDS, 1 mM
dithiothreitol) with 1 mM PMSF and protease cocktail inhib-
itors (Roche, Indianapolis, IN). The samples were then cen-
trifuged at 16,000 g for 10 min at 4°C. The collected super-
natants were used for Western blotting. The protein
concentration in each sample was measured by using Bio-Rad
Protein Assay Reagent (Bio-Rad Laboratories) according to the
manufacturer’s instructions. Western blots were performed by
standard protocols. In brief, total protein (20 g each lane) was
resolved on an SDS–10% polyacrylamide gel and transferred
to nitrocellulose membranes. The levels of Nrf2, catalase, and
SOD1 and SOD2 proteins were analyzed with the following
antibodies: rabbit polyclonal anti-Nrf2 IgG (1:500, Santa Cruz,
Santa Cruz, CA), mouse monoclonal anti-catalase antibody
(1:500; Sigma, St. Louis, MO), rabbit polyclonal anti-SOD1 IgG
(1:1,000; Santa Cruz), and rabbit polyclonal anti-SOD2 IgG
(1:500; Santa Cruz), respectively, followed by detection with
ECL plus Western-blotting detection reagents (GE Healthcare,
Piscataway, NJ). The membranes were scanned on a Bio-Rad
Versa Doc Imaging System (model 4000), and the intensity of
the protein bands was analyzed by using the Bio-Rad Quan-
tity One software (version 4.5.1).
Electrophoretic mobility shift assay
Nrf2-ARE binding was determined using an elec-
trophoretic mobility shift assay (EMSA). Nuclear extracts
were prepared from control and treated mouse embryos by
using NE-PER Nuclear and Cytoplasmic Extraction Reagents
(Pierce Biotechnology, Rockford, IL) by following the man-
ufacturer’s protocol. Binding reactions containing equal
amounts of protein (5 g) and labeled double-strand oligo-
nucleotide probe for mouse glutamate-cysteine ligase
(GCLC) ARE (5-GCACAAAGCGCTGAGTCACGGGGA-
GG-3; 5-GTCCCCGTGACTCAGCGCTTTGTGCG-3; core
ARE sequence underlined) were performed for 20 min at
room temperature. Specific binding was confirmed by using
100-fold excess unlabeled ARE oligonucleotide as a specific
competitor (Gel Shift Assay Kit; Promega, Madison, WI). The
oligonucleotide–protein complex was separated by 4% non-
denaturing polyacrylamide gel electrophoresis followed by
autoradiography. All gel-shift assays were performed for
three sample replicates in each group.
Measurement of antioxidant enzyme activities
Mouse embryos were collected and placed in ice-cold
PBS buffer, pH 7.4. The embryos were sonicated, followed
by centrifugation at 13,000 g for 10 min at 4°C. The su-
pernatants were collected for measurement of antioxidant
enzymes. Total superoxide dismutase (SOD) activity was
determined with the SOD Assay Kit from Dojindo Molec-
ular Technologies, Inc. (Gaithersburg, MD) according to
the manufacturer’s protocol. Catalase activity was mea-
sured with an Amplex Red Catalase Assay Kit (Molecular
Probes, Eugene, OR) according to the manufacturer’s in-
struction.
Measurement of intracellular ROS generation
Intracellular ROS generation was assayed with the method
described by Ozawa et al. (35), with modification. The mouse
embryos were washed twice in assay buffer (130 mM KCl, 5
mM MgCl2, 20 mM NaH2PO4, 20 mM Tris-HCl, 30 mM glu-
cose) and homogenized in 100 l of assay buffer. The ho-
mogenate was centrifuged at 10,000 g for 15 min at 4°C, and
the supernatant, which was equivalent to 40 g of protein,
was transferred to a 96-well microplate. Assay buffer and 2
l of 2,7-dichlorodihydro-fluoroscein diacetate (DCHFDA;
Molecular Probes, Inc., Eugene, OR) (5 mM in DMSO) were
added to the microplate to give a total reaction volume of
200 l. Subsequently, the samples were incubated at 37°C
for 15 min. The fluorescence intensity was monitored for 30
min after excitation at 485 nm and emission at 535 nm by us-
ing a CytoFlor fluorescence plate reader (Perseptive Biosys-
tems, Foster City, CA). The protein concentration in each
sample was measured by using Bio-Rad Protein Assay
Reagent (Bio-Rad Laboratories, Inc.), according to the man-
ufacturer’s instructions. The ROS level was expressed as rel-
ative fluorescence intensity units.
Apoptosis assays
Apoptosis was determined in mouse embryos 12 h after
initial maternal ethanol exposure by using two indepen-
dent assays, caspase-3 activation and Nile blue sulfate vi-
tal staining. Caspase-3 activation was analyzed with West-
ern blot. For this assay, protein preparation and Western
blot were conducted as described earlier. The activation of
caspase-3 was analyzed with rabbit polyclonal against
cleaved caspase-3 (Asp 175) (1:500; Cell Signaling Tech-
nology, Danvers, MA). The extent of apoptosis was ex-
pressed as fold change in caspase-3 activation over con-
trol. Caspase-3 activity was determined with fluorimetric
assay by using the substrate Ac-DEVD-AMC (Caspase-3
Cellular Activity Assay Kit; Calbiochem, San Diego, CA)
according to the manufacturer’s instructions. Nile blue sul-
fate staining was carried out in whole embryos, as de-
scribed previously (11). In brief, embryos were incubated
in a 1:50,000 solution of Nile blue sulfate in Ringer’s solu-
tion at 37°C for 30 min. Stained specimens were then
washed in Ringer’s solution and immediately pho-
tographed by using an Olympus dissecting photomicro-
scope. Both experimental and control embryos were
processed simultaneously for visual comparison of pat-
terns of cell death. Approximately 10 to 15 embryos for
both experimental and control groups were examined.
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Statistical analysis
Statistical analyses were performed by using StatView
software (SAS Institute Inc., Cary, NC). All data are ex-
pressed as mean  SEM of three separate experiments. Sta-
tistical comparisons between groups were analyzed with a
one-way ANOVA. Multiple comparison post-tests between
groups were conducted by using a Tukey test. Differences
between control and treated groups, or between ethanol-
treated group and other groups, were considered significant
at p  0.05.
Results
Exposure to ethanol and pretreatment with D3T in vivo
result in a significant increase in the level of Nrf2 protein
in mouse embryos
To examine the effects of ethanol on Nrf2 signaling in GD
8 mouse embryos, pregnant mice were administered two in-
traperitoneal (i.p.) doses of 25.0% (vol/vol) ethanol at a dos-
age of 2.9 g/kg maternal body weight on GD 8. This dose of
ethanol produced a peak maternal blood alcohol level (BAL)
of 500 mg/dl 4.5 h after the initial dose. At 6 h after the
first dose, the time at which Nrf2 protein level was analyzed,
the maternal BAL is 400 mg/dl (42). Western blot analysis
revealed a moderate increase in the level of Nrf2 protein in
mouse embryos exposed to ethanol in vivo (p  0.05) (Fig. 1).
A major focus of the current study was to examine the po-
tential protective property of the Nrf2 inducer, D3T. To this
end, the effects of in vivo D3T administration on the expres-
sion of Nrf2 and its downstream phase 2 enzymes and anti-
oxidant proteins were determined. Pregnant mice were ad-
ministered D3T 18 hours before ethanol treatment. Western
blot analyses illustrated a 2.8-fold increase in Nrf2 protein
in the embryos whose dams had been treated with both eth-
anol and D3T (Fig. 1).
Exposure to ethanol and pretreatment with D3T in vivo
enhance Nrf2-ARE binding activity in mouse embryos
The antioxidant response element (ARE) is a transcrip-
tional regulatory element involved in the activation of genes
coding for a number of antioxidant proteins and phase 2
detoxifying enzymes. To further substantiate that treatment
with ethanol and D3T can activate Nrf2, we examined the
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FIG. 2. Ethanol and D3T expo-
sure increase the Nrf2-ARE
binding activity in mouse em-
bryos. Nrf2-ARE binding was de-
termined by using an EMSA with
oligonucleotide probe for GCLC
ARE in mouse embryos 6 h after
exposure to ethanol. Embryo
lysates were prepared from
whole embryos treated with veg-
etable oil (Control), 2.9 g/kg eth-
anol (EtOH), pretreated with 5
mg/kg D3T alone (D3T), or
treated with both ethanol and
D3T (EtOHD3T). (A) A repre-
sentative gel-shift image. Lane 1,
No nuclear extract. Lane 2, Nu-
clear extracts of embryos treated
with ethanol and D3T in the pres-
ence of excess specific competitor
probe. Lanes 3–6, Nuclear ex-
tracts of control and treated
mouse embryos in the presence
of labeled probe for GCLC ARE. (B) Bars represent the average values of the Nrf2-ARE binding activity of three gel-shift
assays. Data represent the mean  SEM of three separate experiments. *p  0.05 vs. control. ♣ p  0.05 vs. EtOH.
FIG. 1. Treatment with ethanol and D3T increases the
level of Nrf2 protein in mouse embryos. Western blot was
performed to analyze the level of Nrf2 protein in GD 8 mouse
embryos 6 h after exposure to vegetable oil or ethanol. Em-
bryo lysates were prepared from whole embryos treated
with vegetable oil (Control), 2.9 g/kg ethanol (EtOH), pre-
treated with 5 mg/kg D3T alone (D3T), or treated with both
ethanol and D3T (EtOHD3T). Data are expressed as fold
change over control and represent the mean  SEM of three
separate experiments. *p  0.05 vs. control. ♣ p  0.05 vs.
EtOH.
Nrf2-ARE binding activity in mouse embryos exposed to eth-
anol and D3T. EMSA with an oligonucleotide probe for
mouse GCLC ARE showed an increased Nrf2-ARE binding
activity in mouse embryos exposed to ethanol for 6 h. Pre-
treatment with D3T resulted in a significantly greater in-
crease in Nrf2-ARE binding activity in ethanol-exposed
mouse embryos than that in mouse embryos in control and
ethanol-treated groups (Fig. 2). These data demonstrate that
Nrf2 signaling is involved in ethanol-exposed mouse em-
bryos and that it can be induced by Nrf2 inducer in mouse
embryos.
Ethanol and D3T exposure induce the expression of 
Nrf2 downstream antioxidant genes and 
proteins in mouse embryos
To examine the effects of ethanol on the expression of anti-
oxidant genes that are downstream of Nrf2, mRNA and pro-
tein expression were analyzed by using real-time PCR and
Western blot, respectively. As indicated by mRNA level, eth-
anol exposure for 6 h increased the expression of antioxidant
genes, including cytoplasmic superoxide dismutase (SOD1),
mitochondrial superoxide dismutase (SOD2), extracellular
superoxide dismutase (SOD3), catalase (CAT), glutathione
reductase (GSR), thioredoxin (TRX), and glutathione perox-
idase 1 and 3 (Gpx1 and Gpx3). Except for SOD3, which was
increased by threefold, changes in the mRNA level for the
remainder of the genes tested in this study were less than
onefold over control, indicating that ethanol treatment alone
can induce only a moderate increase in antioxidant gene ex-
pression (Fig. 3). Western blot analysis also illustrated a mod-
erate increase in the expression of SOD1, SOD2, and catalase
protein (Fig. 4), confirming the corresponding changes in
major antioxidant proteins that accompany mRNA induc-
tion.
Pretreatment with D3T resulted in a significantly greater
increase in mRNA and protein expression of antioxidants.
Pretreatment with D3T significantly increased the mRNA
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FIG. 3. Ethanol and D3T expo-
sure induce the expression of
antioxidant genes in mouse em-
bryos. mRNA expression of anti-
oxidant genes was determined by
real-time PCR in GD 8 mouse em-
bryos treated with vegetable oil
(Control), 2.9 g/kg ethanol
(EtOH), pretreated with 5 mg/kg
D3T (D3T), or treated with both
ethanol and D3T (EtOHD3T). All
data are expressed as fold change
over control and represent the
mean  SEM of three separate ex-
periments. *p  0.05 vs. control.
♣ p  0.05 vs. EtOH.
FIG. 4. Treatment with ethanol and D3T induces the expression of antioxidant proteins. Western blot was performed
to analyze the protein expression of catalase, SOD1, and SOD2 in GD 8 mouse embryos 6 hours after exposure to vegetable
oil or ethanol. Embryo lysates were prepared from whole embryos treated with vegetable oil (Control), 2.9 g/kg ethanol
(EtOH), pretreated with 5 mg/kg D3T alone (D3T), or treated with both ethanol and D3T (EtOHD3T). Data are expressed
as fold change over control and represent the mean  SEM of three separate experiments. *p  0.05 vs. control. ♣ p  0.05
vs. EtOH.
expression of antioxidant genes, including SOD1, SOD2,
SOD3, CAT, Trx, Gpx1, Gpx2, Gpx3, and GSR in ethanol-ex-
posed embryos (p  0.05). Among these antioxidant genes,
the expression of SOD1, SOD2, SOD3, and Gpx3 was in-
creased by four-, three-, seven-, and threefold, respectively,
in ethanol-exposed embryos pretreated with D3T as com-
pared with control (Fig. 3). Significant increases in expres-
sion of the major antioxidant proteins SOD1, SOD2, and cata-
lase were also observed in ethanol-exposed mouse embryos
pretreated with D3T (Fig. 4).
Exposure to ethanol and pretreatment with D3T in vivo
result in a significant increase in the activities of
antioxidant enzymes in mouse embryos
Nrf2 controls genes encoding phase 2 detoxifying enzymes
and antioxidant proteins. The orchestrated induction of these
proteins, which is referred to as an Nrf2-mediated defense
response, is crucial for cells in counteracting the adverse ef-
fects of exogenous insults. To test whether upregulation of
Nrf2 by ethanol or D3T can increase the catalytic activity of
selected antioxidant enzymes in mouse embryos, the activi-
ties of two prototypic antioxidant enzymes, SOD and CAT,
were analyzed. As shown in Fig. 5, ethanol exposure for 6
hours resulted in increases in the activities of SOD and CAT.
Pretreatment with D3T resulted in a significantly greater in-
crease in the activities of SOD and CAT in ethanol-exposed
mouse embryos than the group treated with ethanol alone
(Fig. 5), confirming the corresponding changes in the activ-
ities of major antioxidant enzymes that accompany mRNA
and protein induction.
Ethanol exposure and pretreatment with D3T result in
upregulation of genes encoding phase 2 detoxifying
enzymes in mouse embryos
Phase 2 detoxifying enzymes are involved in the detoxifi-
cation of electrophilic chemicals, including carcinogens and
cardiovascular toxicants. To explore whether phase 2 enzymes
can also be induced by in vivo ethanol exposure in early mouse
embryos, mRNA expression of the genes encoding phase 2 en-
zymes was analyzed by using real-time PCR. As shown in Fig.
6, treatment of early mouse embryos with ethanol for 6 h in
vivo increased the mRNA expression of NAD(P) H:quinone ox-
idoreductase-1(NQO-1) and glutathione S-transferase (GSTa2,
GSTm2, GSTm3, and GSTp1). However, similar to ethanol-in-
duced changes in antioxidant gene expression, for most of
these genes, the changes in the mRNA level caused by etha-
nol alone were less than or close to onefold over control. A sig-
nificantly greater increase in the mRNA levels of the genes en-
coding phase 2 enzymes was observed in ethanol-exposed
embryos pretreated with D3T as compared with both the con-
trol group and the groups treated with ethanol alone (p  0.05)
(Fig. 6).
D3T pretreatment significantly reduces ROS generation in
mouse embryos exposed to ethanol in vivo 
For analysis of the effects of D3T pretreatment on ROS
generation in mouse embryos exposed to ethanol in vivo, a
2,7-dichlorodihydro-fluoroscein diacetate (DCHFDA) as-
say was used. Exposure of mouse embryos to ethanol for 6
h in vivo significantly increased ROS generation, confirming
that ethanol can induce ROS generation in early mouse 
embryos. Pretreatment with D3T significantly reduced ROS
generation in mouse embryos exposed to ethanol in vivo (Fig.
7), supporting the premise that chemically induced tran-
scriptional activation of Nrf2 and subsequent induction of
detoxifying and antioxidant proteins can reduce ethanol-in-
duced oxidative stress in early mouse embryos.
D3T pretreatment prevents apoptosis in mouse embryos
exposed to ethanol in vivo 
To determine the effects of D3T treatment on ethanol-in-
duced apoptosis in early mouse embryos, the effect of D3T
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FIG. 6. Exposure to ethanol and D3T results in upregula-
tion of genes encoding phase 2 detoxifying enzymes in
mouse embryos. mRNA expression of phase 2 detoxifying
genes was determined by real-time PCR in GD 8 mouse em-
bryos treated with vegetable oil (Control), 2.9 g/kg ethanol
(EtOH), pretreated with 5 mg/kg D3T (D3T), or treated with
both ethanol and D3T (EtOHD3T). Data are expressed as
fold change over control and represent the mean  SEM of
three separate experiments. *p  0.05 vs. control. ♣ p  0.05
vs. EtOH.
FIG. 5. Ethanol and D3T exposure increase the activities of
antioxidant enzymes, SOD, and catalase in mouse embryos.
Activities of SOD and catalase were determined in GD 8
mouse embryos 6 h after exposure to ethanol. Embryo lysates
were prepared from whole embryos treated with vegetable
oil (Control), 2.9 g/kg ethanol (EtOH), pretreated with 5
mg/kg D3T alone (D3T), or treated with both ethanol and
D3T (EtOHD3T). Data are expressed as fold change over
control and represent the mean  SEM of three separate ex-
periments. *p  0.05 vs. control. ♣ p  0.05 vs. EtOH.
on the activation of caspase-3 was examined. As shown in
Fig. 8A, in control embryos, caspase-3 exists as procaspase-
3 (37 kDa), and little active caspase-3 was observed. In vivo
ethanol treatment induced the activation of caspase-3 in
mouse embryos, as evidenced by a twofold increase in the
expression of its 17-kDa subunit and also resulted in a sig-
nificant increase in the activity of this protease (Fig. 8B). Pre-
treatment with D3T resulted in a significant reduction in the
activation and activity of caspase-3 in ethanol-exposed
mouse embryos as compared with the group treated with
ethanol alone.
Although the caspase-3 activation assay allows rapid
quantification of apoptosis, it precludes localization of apop-
tosis in whole embryos. For this, Nile blue sulfate staining
was used in conjunction with caspase-3 activation assay to
confirm the occurrence and to determine the locations of
apoptosis in whole embryos. As expected, compared with
the untreated and D3T-treated control embryos, those ex-
posed to ethanol showed excessive Nile blue sulfate stain-
ing. The pattern and amount of stain uptake in the ethanol-
exposed embryos was typical of that previously reported for
this exposure paradigm (14). Pretreatment with D3T dra-
matically reduced the ethanol-induced increase in Nile blue
sulfate staining (Fig. 9), indicating that pretreatment with
D3T is, indeed, effective in preventing ethanol-induced
apoptosis in mouse embryos.
Discussion
Utilizing a mouse FASD model, this study provided the
first evidence that in vivo ethanol exposure can activate the
Nrf2 pathway in early embryos. Activation of Nrf2 results
in upregulation of Nrf2 downstream target genes, including
those that encode phase 2 detoxifying enzymes and antiox-
idant proteins such as NQO1, GST, SOD, CAT, TRX, GPx,
and GSR. In addition to gene expression changes, Western
blot analysis revealed a moderate increase in the expression
of Nrf2 and the antioxidant proteins SOD1, SOD2, and cata-
lase, as well as the activities of the antioxidant enzymes,
SOD, and catalase in ethanol-exposed mouse embryo. Be-
cause exposure of embryos to ethanol results in the genera-
tion of ROS, which are known to activate Nrf2 (21), the ob-
served Nrf2 activation was expected. This response is not
unique to ethanol-exposed embryos. Similar effects have
been observed in cells treated with a numbers of other toxic
chemicals, including heavy metals (19, 23), cigarette smoke
(22), and arachidonic acid (17). Of particular interest to this
study is that an increase in Nrf2 protein has also been ob-
served in livers and hepatocytes of alcohol-fed mice and rats
(16).
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FIG. 7. D3T pretreatment significantly reduced ROS gen-
eration in mouse embryos exposed to ethanol in vivo. ROS
generation was measured in GD 8 mouse embryos 6 h after
exposure to vegetable oil (Control), 2.9 g/kg ethanol (EtOH),
pretreatment with 5 mg/kg D3T alone (D3T), or treatment
with both ethanol and D3T (EtOHD3T). Data are expressed
as relative fluorescence intensity units and represent the
mean  SEM of three separate experiments. *p  0.05 vs.
control. ♣ p  0.05 vs. EtOH.
FIG. 8. Pretreatment with D3T
decreases the activation and ac-
tivity of caspase-3 in mouse em-
bryos exposed to ethanol in
vivo. Western blot analyses and
fluorimetric assays were per-
formed to examine the activation
(A) and activity (B) of caspase-3,
respectively, in GD 8 mouse em-
bryos 12 h after exposure to 
vegetable oil or ethanol. Embryo
lysates were prepared from
whole embryos treated with veg-
etable oil (Control), 2.9 g/kg eth-
anol (EtOH), pretreated with 5
mg/kg D3T alone (D3T), or
treated with both ethanol and
D3T (EtOHD3T). Data are ex-
pressed as fold change over con-
trol and represent the mean 
SEM of three separate experi-
ments. *p  0.05 vs. control.
♣ p  0.05 vs. EtOH.
Most eukaryotic cells possess inherent antioxidant defense
mechanisms that include both nonenzymatic neutralization
and enzymatic detoxification of oxygen-derived radicals and
other reactive species (15). However, early mouse embryos
might be expected to have only minimal antioxidant capa-
bilities because the amount of O2 that they metabolize is very
low. Indeed, studies by Davis et al. (13) provided evidence
that neural crest cells cultured from chick embryos have a
deficiency of SOD. The present study showed that Nrf2 is
activated in response to ethanol challenge, leading to the
transcriptional induction of many antioxidant genes. The ter-
atogenic outcome of ethanol exposure is expected to be de-
termined by the balance between the induced ROS produc-
tion and the antioxidant capability, as regulated by Nrf2. The
fact that excessive apoptosis and dysmorphology result from
the exposure regimen used for the present investigation (11,
14) suggests that the ethanol-induced activation of Nrf2 and
its downstream antioxidants is an adaptive response that is
insufficient to be protective. This is supported by this study’s
finding that ethanol can induce only a moderate increase in
antioxidant and detoxifying gene expression.
One of the promising strategies for protection against ox-
idative stress that has received considerable attention is
supplementation with exogenous antioxidants. We showed
previously that exogenous antioxidants, including SOD,
catalase, vitamin E, N-acetylcysteine, and EUK-134, a syn-
thetic SOD and catalase mimetic, significantly diminish
apoptosis and subsequent dysmorphology in early mouse
embryos exposed to ethanol in vitro and in vivo (8–10, 24).
Additionally, Spong et al. (38) have shown that NAP, a neu-
roprotective peptide that has been shown to exhibit anti-
oxidant actions, can decrease ethanol-induced depletion of
reduced glutathione and fetal death. However, the protec-
tion provided by exogenous antioxidants is not complete.
In addition to the fact that teratogenic mechanisms other
than oxidative damage may be involved in the teratogenic
effects of ethanol, the incomplete protection points to the
limitations associated with the use of exogenous antioxi-
dants. The therapeutic efficacy of exogenous antioxidants
may be limited by the facts that (a) their systemic delivery
might not provide adequate concentrations in the target tis-
sue(s), (b) many antioxidants have very limited passage
through a variety of cellular structures and barriers, and (c)
limited numbers of exogenous antioxidants can be simul-
taneously administrated to embryos. In this regard, a more
promising strategy for protecting against oxidative injury
and ethanol’s teratogenesis may be through coordinated
upregulation by chemical inducers of a broad spectrum of
endogenous antioxidants/phase 2 enzymes in embryonic
tissue. As shown by the results of the current study, D3T
is effective in this role.
D3T was shown in this study to induce Nrf2 potently in
mouse embryos. It significantly increased Nrf2 protein lev-
els and Nrf2-ARE binding activity, and strongly induced the
mRNA expression of Nrf2 downstream target genes. Pre-
treatment with D3T also increased the expression of antiox-
idant proteins and the activities of antioxidant enzymes, and
significantly reduced ROS generation in mouse embryos ex-
posed to ethanol in vivo. In addition, it significantly de-
creased ethanol-induced activation and activity of caspase-
3. Caspase-3 is a key effector in the apoptosis pathway,
amplifying the signal from initiator caspases; with its acti-
vation signifying full commitment to cellular disassembly
(41). The presence of activated caspase-3 has been identified
as a marker for active apoptosis (2). Caspase-3 activation has
been observed in apoptosis caused by various inducers, in-
cluding ethanol. For example, ethanol exposure of 7-day
postnatal mice has previously been shown to result in cas-
pase-3 activation in a pattern that corresponds to the pattern
of apoptotic neurodegeneration (20, 33). The significant de-
crease in ethanol-induced caspase-3 activation and activity
in mouse embryos pretreated with D3T suggests that this
compound can reduce ethanol-induced apoptosis in early
mouse embryos. This was shown to be the case, as indicated
by dramatically reduced Nile blue sulfate staining in etha-
nol-exposed embryos pretreated with D3T. These results
demonstrated that this Nrf2 inducer is indeed effective in
preventing oxidative stress and apoptosis in mouse embryos
exposed to ethanol in vivo.
In conclusion, this study demonstrates that Nrf2 signaling
is involved in the induction of antioxidants and detoxifying
enzymes in ethanol-exposed mouse embryos. These findings
provide important information regarding the molecular
mechanisms of ROS signaling and the endogenous cellular
antioxidant defense systems involved in coping with etha-
nol-induced oxidative stress and cell damage. Although fur-
ther study regarding the developmental toxicology of D3T
is required, the potency of this agent in inducing antioxidant
response as well as in preventing ethanol-induced apopto-
sis suggests that further exploration of its antiteratogenic ef-
fect may yield novel strategies for prevention of ethanol-in-
duced birth defects.
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FIG. 9. D3T pretreatment reduces eth-
anol-induced apoptosis. Nile blue sulfate
vital staining of comparably staged
mouse embryos treated with vegetable oil
(Control), pretreated with D3T alone
(D3T), treated with ethanol alone (EtOH),
or treated with both ethanol and D3T
(EtOHD3T) illustrates excessive stain
uptake in mouse embryos exposed to eth-
anol alone (arrows are directed toward
sites of specific uptake in the neural folds
and facial region of GD 8 embryos). Pre-
treatment with D3T results in diminished staining in ethanol-exposed mouse embryos. Shown are representatives of 10 to
15 embryos from several different litters of each group. (For interpretation of the references to color in this figure legend,
the reader is referred to the web version of this article at www.liebertonline.com/ars).
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